Sol-Gel Technologies Ltd. Ordinary Shares (SLGL) Stock Price, Quote & AI Analysis
Live SLGL stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Sol-Gel Technologies Ltd. Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Sol-Gel Technologies Ltd. Ordinary Shares (SLGL), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Sol-Gel Technologies Ltd. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Sol-Gel Technologies Ltd. Ordinary Shares Overview
Company information
Company Overview
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Sol-Gel Technologies Ltd. Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...